News
POREX® Showcases New Innovations in Diagnostics, Liquid Handling and Wound Management at MD&M West 2018
Porex Corporation will showcase advanced solutions for laboratory and medical professionals that speed fluid transfer of diagnostics, improve accuracy and purity in liquid handling, and enhance wound management and improve clinical outcomes. These innovations, offering new...
News
Batavia Biosciences Teams Up with International Consortium to Support Polio Eradication
Batavia Biosciences announces its partnership with an international consortium coordinated by PATH aiming to develop and manufacture safer novel oral poliovirus vaccines (nOPV). The project, funded by the Bill & Melinda Gates Foundation, has the potential...
News
Japanese pharma – no longer ‘lost in translation’
A New Year report from CPhI forecasts 2018 will be a transformative year for Japanese pharma as the market evolves towards growth in generics, biosimilars and increased internationalisation. The CPhI Japan 2018 report – released ahead...
News
Meditraq launches to simplify serialisation data challenge
A new serialisation implementation partner has formed to assist the increasing number of companies needing to meet the data requirements of looming global regulation changes. With the pharmaceutical industry struggling to meet serialisation requirements in over...
News
MEDICAL MANUFACTURING ASIA 2018:Delivering solutions for the future of medtech
Innovative medical technology is an increasingly important driver for delivering efficiencies in the global healthcare system. Through advances in medical technology, precision engineering, micro-manufacturing processes, and IT, medical devices and solutions have become more sophisticated, accurate...
News
TFS International Appoints New Chief Executive Officer
TFS is delighted to announce that Dr János Filakovský MD, PhD, MBA has accepted the position of CEO. János brings a wealth of experience to TFS from the Life Science Industry, including over 20 years serving in different leadership...
News
Amgen’s Xgeva receives US FDA approval for prevention of skeletal-related events in patients with MM
Amgen announced that the U.S. FDA has approved the supplemental Biologics License Application (sBLA) for XGEVA® (denosumab) to expand the currently approved indication for the prevention of skeletal-related events in patients with bone metastases from solid tumors to include...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read